These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The hypothalamic-pituitary-adrenal axis in PTSD: Pathophysiology and treatment interventions. Dunlop BW; Wong A Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 89():361-379. PubMed ID: 30342071 [TBL] [Abstract][Full Text] [Related]
3. Potential peripheral biomarkers associated with the emergence and presence of posttraumatic stress disorder symptomatology: A systematic review. Sbisa AM; Madden K; Toben C; McFarlane AC; Dell L; Lawrence-Wood E Psychoneuroendocrinology; 2023 Jan; 147():105954. PubMed ID: 36308820 [TBL] [Abstract][Full Text] [Related]
4. Genetics of glucocorticoid regulation and posttraumatic stress disorder--What do we know? Castro-Vale I; van Rossum EF; Machado JC; Mota-Cardoso R; Carvalho D Neurosci Biobehav Rev; 2016 Apr; 63():143-57. PubMed ID: 26872620 [TBL] [Abstract][Full Text] [Related]
5. Glucocorticoids and Hippocampal Structure and Function in PTSD. Szeszko PR; Lehrner A; Yehuda R Harv Rev Psychiatry; 2018; 26(3):142-157. PubMed ID: 29734228 [TBL] [Abstract][Full Text] [Related]
6. Basal blood DHEA-S/cortisol levels predicts EMDR treatment response in adolescents with PTSD. Usta MB; Gumus YY; Say GN; Bozkurt A; Şahin B; Karabekiroğlu K Nord J Psychiatry; 2018 Apr; 72(3):164-172. PubMed ID: 29171317 [TBL] [Abstract][Full Text] [Related]
7. [Posttraumatic stress disorder (PTSD) as a consequence of the interaction between an individual genetic susceptibility, a traumatogenic event and a social context]. Auxéméry Y Encephale; 2012 Oct; 38(5):373-80. PubMed ID: 23062450 [TBL] [Abstract][Full Text] [Related]
8. Fear extinction and memory reconsolidation as critical components in behavioral treatment for posttraumatic stress disorder and potential augmentation of these processes. Smith NB; Doran JM; Sippel LM; Harpaz-Rotem I Neurosci Lett; 2017 May; 649():170-175. PubMed ID: 28065842 [TBL] [Abstract][Full Text] [Related]
12. Translating Molecular and Neuroendocrine Findings in Posttraumatic Stress Disorder and Resilience to Novel Therapies. DePierro J; Lepow L; Feder A; Yehuda R Biol Psychiatry; 2019 Sep; 86(6):454-463. PubMed ID: 31466562 [TBL] [Abstract][Full Text] [Related]
13. Biological markers and diagnostic accuracy in the genetics of posttraumatic stress disorder. Radant A; Tsuang D; Peskind ER; McFall M; Raskind W Psychiatry Res; 2001 Jul; 102(3):203-15. PubMed ID: 11440771 [TBL] [Abstract][Full Text] [Related]
14. Pre-treatment cortisol awakening response predicts symptom reduction in posttraumatic stress disorder after treatment. Rapcencu AE; Gorter R; Kennis M; van Rooij SJH; Geuze E Psychoneuroendocrinology; 2017 Aug; 82():1-8. PubMed ID: 28482208 [TBL] [Abstract][Full Text] [Related]
15. The downside of strong emotional memories: how human memory-related genes influence the risk for posttraumatic stress disorder--a selective review. Wilker S; Elbert T; Kolassa IT Neurobiol Learn Mem; 2014 Jul; 112():75-86. PubMed ID: 24012801 [TBL] [Abstract][Full Text] [Related]
16. A review on inflammatory cytokine-induced alterations of the brain as potential neural biomarkers in post-traumatic stress disorder. Kim YK; Amidfar M; Won E Prog Neuropsychopharmacol Biol Psychiatry; 2019 Apr; 91():103-112. PubMed ID: 29932946 [TBL] [Abstract][Full Text] [Related]
17. Can pharmacological and psychological treatment change brain structure and function in PTSD? A systematic review. Thomaes K; Dorrepaal E; Draijer N; Jansma EP; Veltman DJ; van Balkom AJ J Psychiatr Res; 2014 Mar; 50():1-15. PubMed ID: 24321592 [TBL] [Abstract][Full Text] [Related]